Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB Jr, Peterson ED; PREVENT IV Investigators.
Goyal A, et al. Among authors: kouchoukos nt.
Ann Thorac Surg. 2007 Mar;83(3):993-1001. doi: 10.1016/j.athoracsur.2006.10.046.
Ann Thorac Surg. 2007.
PMID: 17307447
Clinical Trial.